248
Participants
Start Date
September 24, 2015
Primary Completion Date
January 12, 2018
Study Completion Date
January 12, 2018
Pridopidine
45 mg BID
Teva Investigational Site 33027, Vienna
Teva Investigational Site 78057, Westmead
Teva Investigational Site 78055, Caulfield South
Teva Investigational Site 78058, West Perth
Teva Investigational Site 12203, New York
Teva Investigational Site 32408, Berlin
Teva Investigational Site 12200, Manhasset
Teva Investigational Site 35124, Marseille
Teva Investigational Site 12198, Rochester
Teva Investigational Site 12209, Pittsburgh
Teva Investigational Site 12196, Washington D.C.
Teva Investigational Site 30080, Milan
Teva Investigational Site 12206, Baltimore
Teva Investigational Site 12210, Richmond
Teva Investigational Site 12211, Winston-Salem
Teva Investigational Site 35165, Toulouse
Teva Investigational Site 32410, Bochum
Teva Investigational Site 32409, Münster
Teva Investigational Site 35123, Angers
Teva Investigational Site 30083, Florence
Teva Investigational Site 35125, Lille
Teva Investigational Site 30081, San Giovanni Rotondo
Teva Investigational Site 35121, Salouël
Teva Investigational Site 12201, Englewood
Teva Investigational Site 30082, Napoli
Teva Investigational Site 12208, Salt Lake City
Teva Investigational Site 32407, Ulm
Teva Investigational Site 12204, Los Angeles
Teva Investigational Site 35122, Créteil
Teva Investigational Site 50213, Moscow
Teva Investigational Site 50215, Kazan'
Teva Investigational Site 50214, Nyznij Novgorod
Teva Investigational Site 33021, Innsbruck
Teva Investigational Site 11036, Toronto
Teva Investigational Site 38059, Leiden
Teva Investigational Site 53150, Gdansk
Teva Investigational Site 53149, Krakow
Teva Investigational Site 53148, Poznan
Teva Investigational Site 53151, Warsaw
Teva Investigational Site 34058, Birmingham
Teva Investigational Site 34054, Cambridge
Teva Investigational Site 34059, Cardiff
Teva Investigational Site 34055, Manchester
Teva Investigational Site 34061, Newcastle upon Tyne
Teva Investigational Site 34056, Oxford
Teva Investigational Site 34057, Sheffield
Lead Sponsor
Prilenia
INDUSTRY